{"id":34651,"date":"2024-11-26T17:06:14","date_gmt":"2024-11-26T17:06:14","guid":{"rendered":"https:\/\/bnssghealthiertogether.org.uk\/?page_id=34651"},"modified":"2024-11-26T17:06:14","modified_gmt":"2024-11-26T17:06:14","slug":"how-can-we-optimise-the-management-of-patients-with-inflammatory-bowel-disease","status":"publish","type":"page","link":"https:\/\/bnssghealthiertogether.org.uk\/sq\/integrated-care-board\/research-and-evidence\/our-research-portfolio\/type-2-rcf-funded-projects\/how-can-we-optimise-the-management-of-patients-with-inflammatory-bowel-disease\/","title":{"rendered":"Si mund t\u00eb optimizojm\u00eb menaxhimin e pacient\u00ebve me S\u00ebmundje Inflamatore t\u00eb Zorr\u00ebve?"},"content":{"rendered":"
Seksioni me titull module-1<\/span><\/a>
\r\n
\r\n

Si mund t\u00eb optimizojm\u00eb menaxhimin e pacient\u00ebve me S\u00ebmundje Inflamatore t\u00eb Zorr\u00ebve?<\/h1>\n

Cila \u00ebsht\u00eb pyetja e propozuar e k\u00ebrkimit?<\/h2>\n

Si mund t\u00eb optimizojm\u00eb menaxhimin e pacient\u00ebve me S\u00ebmundje Inflamatore t\u00eb Zorr\u00ebve?<\/p>\n

Financimi<\/h2>\n

Financimi i Aft\u00ebsive K\u00ebrkimore t\u00eb BNSSG ICB.<\/p>\n

Cili \u00ebsht\u00eb problemi?<\/h2>\n

S\u00ebmundja inflamatore e zorr\u00ebve (IBD), s\u00ebmundja e Crohn-it (CD) dhe koliti ul\u00e7eroz (UC), jan\u00eb gjendje inflamatore kronike t\u00eb zorr\u00ebve q\u00eb prekin 500,000 (1:123) njer\u00ebz n\u00eb Mbret\u00ebrin\u00eb e Bashkuar. IBD \u00ebsht\u00eb nj\u00eb gjendje e p\u00ebrjetshme, e cila zakonisht diagnostikohet tek t\u00eb rinjt\u00eb e mosh\u00ebs 10 deri n\u00eb 30 vje\u00e7, duke shkaktuar paaft\u00ebsi t\u00eb konsiderueshme dhe shpesh duke kufizuar aft\u00ebsin\u00eb p\u00ebr t\u00eb punuar normalisht.<\/p>\n

Trajtimi mjek\u00ebsor i IBD-s\u00eb u revolucionarizua rreth 30 vjet m\u00eb par\u00eb me futjen e terapis\u00eb s\u00eb par\u00eb biologjike, infliximab. Q\u00eb at\u00ebher\u00eb, disa terapi biologjike dhe me molekula t\u00eb vogla jan\u00eb zhvilluar p\u00ebr t'u p\u00ebrdorur n\u00eb IBD.<\/p>\n

Rritja e opsioneve nuk \u00ebsht\u00eb shoq\u00ebruar nga literatura p\u00ebr t\u00eb udh\u00ebzuar mjek\u00ebt se cilat ila\u00e7e duhet t\u00eb p\u00ebrdorin s\u00eb pari dhe si t\u00eb kalojn\u00eb tek t\u00eb tjerat n\u00eb rast t\u00eb d\u00ebshtimit t\u00eb trajtimit. T\u00eb dh\u00ebnat paraprake sugjerojn\u00eb se ka nj\u00eb ndryshim t\u00eb ndjesh\u00ebm n\u00eb praktikat e recetave dhe literatura aktuale nuk na lejon t\u00eb optimizojm\u00eb rezultatin p\u00ebrmes p\u00ebrdorimit t\u00eb burimeve. Kjo vonon faljen e s\u00ebmundjes p\u00ebr pacient\u00ebt dhe shp\u00ebrdoron burime t\u00eb r\u00ebnd\u00ebsishme.<\/p>\n

Cili \u00ebsht\u00eb q\u00ebllimi i hulumtimit?<\/h2>\n

P\u00ebr t\u00eb zhvilluar nj\u00eb udh\u00ebrr\u00ebfyes p\u00ebr prioritizimin e terapis\u00eb biologike dhe molekulave t\u00eb vogla p\u00ebr menaxhimin e s\u00ebmundjes inflamatore t\u00eb zorr\u00ebve n\u00eb baz\u00eb t\u00eb efektivitetit klinik, efektivitetit t\u00eb kostos dhe p\u00ebrvoj\u00ebs s\u00eb pacientit.<\/p>\n

Si do t\u00eb arrihet kjo?<\/h2>\n

S\u00eb pari, do t\u00eb p\u00ebrshkruajm\u00eb kujdesin p\u00ebr pacient\u00ebt me s\u00ebmundje inflamatore t\u00eb zorr\u00ebve n\u00eb t\u00eb gjith\u00eb BNSSG-n\u00eb, duke u fokusuar te p\u00ebrshkrimi lokal i ila\u00e7eve dhe ndryshimet sipas zon\u00ebs dhe demografis\u00eb s\u00eb pacient\u00ebve.<\/p>\n

S\u00eb dyti, do t\u00eb mbledhim t\u00eb dh\u00ebna p\u00ebr rezultatet klinike, si\u00e7 jan\u00eb sh\u00ebnuesit e gjakut dhe jasht\u00ebqitjes p\u00ebr t\u00eb k\u00ebrkuar pranin\u00eb e inflamacionit, si dhe ngjarjet an\u00ebsore, t\u00eb tilla si shtrimet n\u00eb spital, kurset me steroide dhe nd\u00ebrhyrjet kirurgjikale. K\u00ebto t\u00eb dh\u00ebna do t\u00eb p\u00ebrdoren p\u00ebr t\u00eb krahasuar strategjit\u00eb e trajtimit, duke siguruar t\u00eb dh\u00ebna nga bota reale p\u00ebr t\u00eb plot\u00ebsuar at\u00eb q\u00eb dihet tashm\u00eb rreth efikasitetit klinik t\u00eb k\u00ebtyre ila\u00e7eve n\u00eb mjedisin e provave klinike.<\/p>\n

S\u00eb treti, kosto-efektiviteti mund t\u00eb vler\u00ebsohet duke llogaritur nj\u00eb \u2018kosto p\u00ebr remision\u2019. P\u00ebr kontekst shtes\u00eb, ne do t\u00eb p\u00ebrfshijm\u00eb koston e kontakteve klinike urgjente pasuese p\u00ebr terapit\u00eb e d\u00ebshtuara dhe rezultatet klinike an\u00ebsore me secilin trajtim.<\/p>\n

S\u00eb fundi, do t\u00eb p\u00ebrdorim intervistat me pacient\u00ebt p\u00ebr t\u00eb eksploruar p\u00ebrvoj\u00ebn e pacientit, p\u00ebr t\u00eb identifikuar rezultate t\u00eb r\u00ebnd\u00ebsishme p\u00ebr pacient\u00ebt dhe p\u00ebr t\u00eb theksuar v\u00ebshtir\u00ebsit\u00eb e zakonshme p\u00ebr pacient\u00ebt q\u00eb trajtohen me k\u00ebto ila\u00e7e, me fokus eksplorimin e pabarazive sh\u00ebndet\u00ebsore.<\/p>\n

Kush po e udh\u00ebheq hulumtimin?<\/h2>\n

Dr. Jennifer Phillips, Fellowship Akademike Klinike n\u00eb Gastroenterologji.<\/p>\n

Informacion i m\u00ebtejsh\u00ebm:<\/h2>\n

P\u00ebr m\u00eb shum\u00eb informacion ose p\u00ebr t'u p\u00ebrfshir\u00eb n\u00eb k\u00ebt\u00eb projekt, ju lutemi kontaktoni bnssg.research@nhs.net<\/p>\n <\/div>\r\n <\/section><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"

Section titled module-1 How can we optimise the management of patients with Inflammatory Bowel Disease? What is the proposed research question? How can we optimise the management of patients with Inflammatory Bowel Disease? Funding BNSSG ICB Research Capability Funding. What is the problem? Inflammatory bowel disease (IBD), Crohn\u2019s Disease (CD) and ulcerative colitis (UC), are […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":32896,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"tags":[],"class_list":["post-34651","page","type-page","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/bnssghealthiertogether.org.uk\/sq\/wp-json\/wp\/v2\/pages\/34651","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bnssghealthiertogether.org.uk\/sq\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/bnssghealthiertogether.org.uk\/sq\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/bnssghealthiertogether.org.uk\/sq\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/bnssghealthiertogether.org.uk\/sq\/wp-json\/wp\/v2\/comments?post=34651"}],"version-history":[{"count":1,"href":"https:\/\/bnssghealthiertogether.org.uk\/sq\/wp-json\/wp\/v2\/pages\/34651\/revisions"}],"predecessor-version":[{"id":34652,"href":"https:\/\/bnssghealthiertogether.org.uk\/sq\/wp-json\/wp\/v2\/pages\/34651\/revisions\/34652"}],"up":[{"embeddable":true,"href":"https:\/\/bnssghealthiertogether.org.uk\/sq\/wp-json\/wp\/v2\/pages\/32896"}],"wp:attachment":[{"href":"https:\/\/bnssghealthiertogether.org.uk\/sq\/wp-json\/wp\/v2\/media?parent=34651"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bnssghealthiertogether.org.uk\/sq\/wp-json\/wp\/v2\/tags?post=34651"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}